Epiblast Stem Cell Subpopulations Represent Mouse Embryos of Distinct Pregastrulation Stages  by Han, Dong Wook et al.
Epiblast Stem Cell Subpopulations
Represent Mouse Embryos
of Distinct Pregastrulation Stages
Dong Wook Han,1 Natalia Tapia,1 Jin Young Joo,1 Boris Greber,1 Marcos J. Arau´zo-Bravo,1 Christof Bernemann,1
Kinarm Ko,2,3 Guangming Wu,1 Martin Stehling,1 Jeong Tae Do,4 and Hans R. Scho¨ler1,5,*
1Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Ro¨ntgenstrasse 20,
48149 Mu¨nster, Germany
2Center for Stem Cell Research, Institute of Biomedical Sciences and Technology
3Department of Neuroscience, School of Medicine
Konkuk University, Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea
4Laboratory of Stem Cell and Developmental Biology, CHA Stem Cell Institute, CHA University, 605-21 Yoeksam 1-dong, Gangnam-gu,
Seoul 135-081, Republic of Korea
5University of Mu¨nster, Medical Faculty, Domagkstrasse 3, 48149 Mu¨nster, Germany
*Correspondence: office@mpi-muenster.mpg.de
DOI 10.1016/j.cell.2010.10.015SUMMARY
Embryonic stem cells (ESCs) comprise at least two
populations of cells with divergent states of pluripo-
tency. Here, we show that epiblast stem cells
(EpiSCs) also comprise two distinct cell populations
that can be distinguished by the expression of
a specific Oct4-GFP marker. These two subpopula-
tions, Oct4-GFP positive and negative EpiSCs, are
capable of converting into each other in vitro. Oct4-
GFP positive and negative EpiSCs are distinct from
ESCswith respect to global gene expression pattern,
epigenetic profile, and Oct4 enhancer utilization.
Oct4-GFP negative cells share features with cells of
the late mouse epiblast and cannot form chimeras.
However, Oct4-GFP positive EpiSCs, which only
represent a minor EpiSC fraction, resemble cells of
the early epiblast and can readily contribute to
chimeras. Our findings suggest that the rare ability
of EpiSCs to contribute to chimeras is due to the
presence of the minor EpiSC fraction representing
the early epiblast.
INTRODUCTION
Four different types of pluripotent stem cells have been estab-
lished in culture to date: EC (embryonal carcinoma) cells from
teratocarcinomas, ES (embryonic stem) cells from the inner cell
mass (ICM), EG (embryonic germ) cells from PGCs (primordial
germ cells), and EpiSCs (epiblast stem cells) from developing
epiblasts (Lovell-Badge, 2007). ES, EC, and EG cells are capable
of efficiently forming both teratomas and chimeras. However,
although EpiSCs readily form teratomas, they rarely form
chimeras (Brons et al., 2007; Tesar et al., 2007). This featuresuggests that EpiSCsmay exhibit restricted pluripotency relative
to other pluripotent stem cells despite similarities in gene expres-
sion and epigenetic profile (Chou et al., 2008). To our knowledge,
EpiSCs represent only one cell type exhibiting this restricted
potency. This limited potency of EpiSCs may be inherent to the
tissue of origin or newly arises from the different culture environ-
ment of EpiSCs compared with ES cells (ESCs). This latter
possibility is corroborated by evidence indicating that mouse
ESCs require LIF and BMP4 to maintain pluripotency (Ying
et al., 2003), whereas EpiSCs require bFGF and Activin A (Brons
et al., 2007; Tesar et al., 2007). The low potency of EpiSCs can
also be explained by the inability of these cells to grow and
survive as single cells when injected into a blastocyst, preventing
them from incorporating into the ICM. Another possible explana-
tion concerns the developmental stage gap of the cells
involved—donor EpiSCs are of embryonic day 5.5 (E5.5) to
E7.5, whereas recipient blastocysts are of E3.5. However,
these possible explanations do not fully explain the distinct plu-
ripotency of EpiSCs. A final explanation may be that EpiSCs are
actually heterogeneous in nature and thus comprise at least two
distinct subpopulations, onewith higher developing potency and
the other with lower potency, possibly accounting for the
apparent discrepancy in the potency of EpiSCs observed with
different in vivo development assays.
ESCs have long been considered to represent a homogeneous
population of cells; however, recent studies based on Stella
(Dppa3) and Rex1 (Zfp42) expression have demonstrated that
ESCs comprise a heterogeneous cell population (Hayashi
et al., 2008; Toyooka et al., 2008). Different cell subpopulations
represent different in vivo developmental stages, with a dynamic
interchange between cells of an ICM-like state and those of an
epiblast- or primitive ectoderm-like state. Similarly, ESC expres-
sion levels of stage-specific embryonic antigen 1 (SSEA1) and
platelet endothelial cell adhesion molecule 1 (Pecam1) have
been shown to correlate with ESC pluripotency (Furusawa
et al., 2004). Strikingly, intermittent Nanog expression hasCell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc. 617
Figure 1. Characterization of GOF18
EpiSCs
(A) Morphology and Oct4-GFP expression in the
established GOF18 EpiSC line at early and late
passages.
(B and C) Scatter plots of global gene expression
microarrays comparing GOF18 EpiSCs with T9
EpiSCs (B) and ESCs (C). The black lines delineate
the boundaries of 2-fold difference in gene expres-
sion levels. Genes highly expressed in ordinate
samples compared with abscissas samples
are shown as green circles; those less expressed
are shown as red. Positions of pluripotent cell
(Pou5f1/Oct4, Sox2, Nanog, Klf2, Klf4, Klf5,
Sall4, Dnmt3l, Esrrb, Fbxo15, and Zfp42/Rex1),
germ cell (Stella [Dppa3], Dppa4, Dppa5, Iftm3
[Fragilis]), and epiblast (Fgf5, T) markers are
indicated with orange dots. The color bar to
the right indicates the scattering density; the
higher the scattering density, the darker the blue
color. Gene expression levels are depicted on
log2 scale.
(D) Protein levels of pluripotency markers in
EpiSCs. Levels of Oct4, Nanog, and Sox2 were
compared in ESCs and EpiSCs by western blot;
3T3 cells were used as a negative control.
(E) Immunofluorescence analysis for Oct4, Nanog,
and Sox2 in ESCs and EpiSCs. DAPI was used for
nuclear staining.been associated with distinct functional ESC phenotypes
(Chambers et al., 2007). Thus, undifferentiated ESC cultures
comprise cells of different pluripotency levels corresponding to
different developmental stages in the embryo. To date, EpiSCs
have been considered to represent a homogeneous pluripotent
cell population due to their high methylation compared with
ESCs. This epigenetic profile may result in reduced EpiSC plas-
ticity, thus preventing cellular heterogeneity, as observed in
ESCs (Hayashi et al., 2008; Toyooka et al., 2008).
Primitive ectoderm (PrE) cells of developing epiblasts have
been generally described to be incapable of contributing to
chimera formation, although they still retain differentiation poten-
tial andcangive rise to cells of all threegerm layers (Gardner et al.,
1985; Lawson et al., 1991; Tesar et al., 2007). However, Gardner
et al. demonstrated that PrE cells froman early stage, such as E5,
still have the capability for chimeric contribution, but they lose it
within the next 24 hr (Gardner et al., 1985). Therefore, if we
consider the developing potency of early-stage epiblasts and
the heterogeneity of ESCs, we can surmise that EpiSCs may
comprise a heterogeneous population, like ESCs, and that
a minor or rare subpopulation of EpiSCs exists that contributes
to chimera formation, with themajor EpiSC subpopulation having
no such developing potency, like late-stage epiblasts.
In this study, we explored the distinct pluripotential state of
EpiSCs by investigating the homogeneity of EpiSCs in culture.
Based on the distinct expression of an Oct4-GFP transgene,
we found that EpiSCs are not homogeneous but, rather,618 Cell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc.comprise two distinct cell subpopulations: anOct4-GFP positive
population and an Oct4-GFP negative population. These two
subpopulations displayed clear differences in molecular charac-
teristics and developmental potential, including capability for
chimera formation. We show that these two subpopulations
do not represent spontaneously converted ES-like cells but,
rather, resemble cells of early- and late-stage postimplantation
embryos. Therefore, our findings suggest that the observed
discrepancy in a pluripotential capacity of EpiSCs (teratoma
versus chimera formation) is due to the presence of two function-
ally distinct subpopulations of EpiSCs in culture.
RESULTS
Dynamic Expression of an Oct4-GFP Transgene
in Established GOF18 EpiSCs
Epiblast stem cells were derived from GOF18 (genomic Oct4
fragment, 18 kb) mice containing a GFP transgene under the
control of the entire regulatory region of the Oct4 gene (Yeom
et al., 1996). A characteristic feature ofmouse EpiSCs is the pref-
erential use of the proximal enhancer (PE) over the distal
enhancer (DE) for Oct4 gene transcription (Tesar et al., 2007).
Thus, both established EpiSCs from GOF18 mice and postim-
plantation epiblasts should theoretically express Oct4 and be
Oct4-GFP positive. We first examined the expression of Oct4-
GFP in both established EpiSCs (Figure 1A) and postimplanta-
tion epiblasts (Figure 5E). Whereas the in vivo epiblast was
Figure 2. Dynamic Expression of Oct4-GFP
in GOF18 EpiSCs
(A) Percentage of Oct4-GFP positive cells in
EpiSCs measured by FACS sorting.
(B) Oct4-GFP positive and Oct4-GFP negative
EpiSCs were FACS sorted and cultured sepa-
rately. An Oct4-GFP negative colony from Oct4-
GFP positive cells and an Oct4-GFP positive
colony from Oct4-GFP negative cells observed
under fluorescence microscope after 1 week in
culture are shown.
(C) Percentage of Oct4-GFP positive cells from
both Oct4-GFP positive and Oct4-GFP negative
cells wasmeasured by FACS 7 days after the initial
sorting.
(D) Summary of the clonal assay. FACS-sorted
Oct4-GFP positive and negative single cells were
plated on 96-well plates, and Oct4-GFP expres-
sion was monitored under fluorescence micro-
scope during 1 week. The numbers of clonal cell
lines containing only GFP positive cells, only GFP
negative cells, or a mixture of GFP positive and
negative cells are indicated.Oct4-GFP positive, only a very low percentage of established
GOF18 EpiSCs retained Oct4-GFP expression after a few
passages (Figure 1A and Figure 2A; see also Figure 5E).
GOF18 EpiSCs exhibited a global gene expression profile very
similar to that of an independently derived EpiSC line but distinct
from that of ESCs, confirming that GOF18 cells are bona fide
EpiSCs (Tesar et al., 2007) (Figures 1B and 1C). Oct4 protein
levels were similar in ESCs and EpiSCs, but Sox2 and Nanog
protein levels were lower in EpiSCs (Figures 1D and 1E), consis-
tent with published data (Silva et al., 2009).
Therefore, the expression of the Oct4-GFP transgene did not
appear to correspond to that of the endogenous Oct4 gene in
GOF18 EpiSCs, prompting us to speculate that this may be
due to an adaptation of the in vivo epiblast to the in vitro culture
conditions. Similarly, the ICM undergoes adaptive modifications
during the establishment of ESCs, as previously described
(Buehr and Smith, 2003; Rossant, 2001). Thus, inactivation of
the Oct4-GFP transgene might actually result from epigenetic
modifications occurring in the in vitro culture—a change that
may affect the GFP transgene, but not the endogenous Oct4
locus at the gene and protein levels. However, 0.5% of GOF18
EpiSCs remained Oct4-GFP positive after serial passages
(Figure 2A).
Next, we sought to investigate the characteristics of thisOct4-
GFP positive population of EpiSCs. To this end, we sorted Oct4-
GFP positive and negative cells by fluorescence-activated cell
sorting (FACS) and cultured them separately. Of interest, 48 hr
after FACS sorting, Oct4-GFP positive cells started to lose
GFP expression. On the other hand, some Oct4-GFP negative
cells started to gain GFP expression (Figure 2B). After 1 week
in culture, the percentage of Oct4-GFP positive cells in each
culture was similar to that of the parental nonsorted EpiSCs.
Oct4-GFP negative EpiSCs gave rise to a small proportion of
Oct4-GFP positive EpiSCs (0.2%Oct4-GFP positive), whereas
the majority of Oct4-GFP positive EpiSCs converted to Oct4-
GFP negative EpiSCs (0.5% Oct4-GFP positive) (Figure 2C).To better characterize this conversion, we performed a clonal
assay (Figure 2D). We then FACS sorted single Oct4-GFP posi-
tive and negative cells in 96-well plates (10 3 96-well plates
with Oct4-GFP negative EpiSCs and 5 3 96-well plates with
Oct4-GFP positive EpiSCs). Fifty-eight of 960 Oct4-GFP nega-
tive EpiSCs and 30 of 480 Oct4-GFP positive EpiSCs had
survived after 1 day in culture. After 1 week in culture, five
Oct4-GFP negative clonal lines showed partial reactivation of
the Oct4-GFP transgene. Similarly, 12 Oct4-GFP positive single
cell lines lost Oct4-GFP expression—either partially or entirely
(Figure 2D). These results indicated that both Oct4-GFP positive
and negative EpiSCs had the ability to interconvert, resulting in
a state of dynamic equilibrium between Oct4-GFP positive and
negative EpiSCs in culture.
Oct4-GFP Positive and Negative EpiSCs Have Distinct
Gene Expression Profiles
Next, we assessed whether the Oct4-GFP positive and negative
subpopulations differ at the molecular level. The global gene
expression profile of both FACS-sorted subpopulations was
determined by microarray analysis. The global gene expression
profile of Oct4-GFP negative EpiSCs, which represented 99%
of the entire GOF18 EpiSC culture, matched that of the parental
nonsorted GOF18 EpiSCs (Figure 3A). Moreover, the global
expression profile of the Oct4-GFP positive fraction was very
similar to that of the negative fraction, but both differedmarkedly
from that of an ESC control transcriptome (Figures 3A and 3B).
In other words, both EpiSC subpopulations indeed constitute
EpiSCs and not, for example, spontaneously converted ES-like
cells. ESCmarker genes, such as Klf2, Klf4,Dnmt3l, Esrrb, Stella
(Dppa3), Fbxo15, Rex1 (Zfp42), and Dppa5, were upregulated in
the Oct4-GFP positive subpopulation compared with the Oct4-
GFP negative fraction (Figure 3A and Figure S1 available online).
Similarly, EpiSC markers, such as Fgf5 and Brachyury (T), were
downregulated in GFP positive subpopulation compared with
negative EpiSCs. Overall, these findings indicate that Oct4-GFPCell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc. 619
Figure 3. Oct4-GFP Positive and Negative EpiSCs Have Distinct Gene Expression and Epigenetic Profiles
(A) Scatter plots of global gene expression microarray comparing Oct4-GFP negative and positive EpiSCs with nonsorted EpiSCs.
(B) Scatter plots of global gene expressionmicroarrays comparingOct4-GFP negative and positive EpiSCswith ESCs. The black lines delineate the boundaries of
2-fold difference in gene expression levels. Genes highly expressed in ordinate samples comparedwith abscissas samples are shown as green circles; those less
expressed are shown as red. Positions of pluripotent cell (Pou5f1/Oct4, Sox2, Nanog, Klf2, Klf4, Klf5, Sall4, Dnmt3l, Esrrb, Fbxo15, and Zfp42/Rex1), germ cell
(Stella [Dppa3], Dppa4, Dppa5, Iftm3 [Fragilis]), and epiblast (Fgf5, T) markers are indicated with orange dots. The color bar to the right indicates the scattering
density; the higher the scattering density, the darker the blue color. Gene expression levels are depicted on log2 scale.
(C) Heat map of global gene expression patterns in ESCs,Oct4-GFP positive and negative EpiSCs, T9 EpiSCs, and GOF18 EpiSCs. The color bar at top codifies
the gene expression in log2 scale. Red and blue colors indicate high and low gene expression, respectively.
(D) Hierarchical clustering shows that Oct4-GFP positive EpiSCs clustered close to the parental EpiSCs or T9 EpiSCs, but not to ESCs.
(E) DNAmethylation status of the promoter regions of both the endogenousOct4 gene and theOct4-GFP transgenewas determined by bisulfite sequencing PCR.
(F) Dppa5, Stella (Dppa3), Vasa, and Fragilis (Iftm3) promoter regions were analyzed by bisulfite sequencing PCR in ESCs, MEFs, and PGCs, as well as in Oct4-
GFP positive and negative EpiSCs.
See also Figure S1.positive cells were still EpiSCs by identity, but they differed from
the more abundant EpiSC subpopulation by the expression of
several prominent marker genes.620 Cell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc.Recent reports have described that EpiSCs are capable of
converting to an ES-like state under specific culture conditions
(Bao et al., 2009; Greber et al., 2010; Guo et al., 2009; Hanna
Figure 4. Oct4-GFP Positive and Negative
EpiSCs Show Distinct ESC Conversion
Efficiency
(A) Conversion of both the Oct4-GFP positive and
negative EpiSCs to an ES-like cell state using
a conversion condition (2i+LIF). Morphology and
alkaline phosphatase (AP) activity of EpiSCs after
4 days of treatment are shown.
(B) Relative conversion efficiency of Oct4-GFP
positive and negative EpiSCs was determined by
counting the number of AP-positive colonies.
Data represent mean ± SEM of triplicates; n = 3.
(C) Dppa5, Stella, Vasa, and Fragilis promoter
regions in the converted ES-like cells were
analyzed by bisulfite sequencing PCR.
See also Figure S2.et al., 2009).We therefore sought to further rule out the possibility
that Oct4-GFP positive EpiSCs represented EpiSCs that had
converted to an ES-like state. As revealed by hierarchical clus-
tering, Oct4-GFP positive as well as Oct4-GFP negative EpiSCs
clearly differed from ESCs and clustered with an independent
EpiSC line (Figures 3C and 3D). Thus, the Oct4-GFP positive
EpiSC subpopulation did not represent EpiSC cells that had
spontaneously converted to an ES-like state.
Epigenetic Differences between Oct4-GFP Positive
and Negative EpiSCs
We then asked whether at least some of the differences in gene
expression between Oct4-GFP positive and negative EpiSCs
(Figure 3A) could have resulted from differential epigenetic modi-
fications. To this end, we determined the DNAmethylation status
of the endogenous and transgenic Oct4 loci in both Oct4-GFP
positive and negative EpiSCs. Consistent with the gene expres-
sion profiling data (Figure 3A), the promoter regions of endoge-
nous Oct4 were completely unmethylated in both subpopula-
tions (Figure 3E). However, the Oct4-GFP transgene promoter
was hypomethylated in Oct4-GFP positive EpiSCs but highly
methylated in Oct4-GFP negative EpiSCs (Figure 3E). These
data indicate that the mechanism regulating the dynamic Oct4-
GFP fluctuations in EpiSC culture is related to the differential
DNA methylation status of the Oct4-GFP promoter in Oct4-
GFP positive and negative EpiSCs.
Next, we assessed whether Oct4-GFP positive cells may
represent early PGCs. To this end, we examined the promoter
regions of the germ cell markers Stella (Dppa3), Vasa, and Fragi-
lis (Iftm3) in ESCs,Oct4-GFP positive aswell as negative EpiSCs,
PGCs, and mouse embryonic fibroblasts (MEFs). As expected,
all promoter regions examined were fully methylated in MEFsCell 143, 617–627, Nbut completely unmethylated in PGCs.
All of these genes exhibited an imprinted
methylation pattern in ESCs, which is due
to the heterogeneous expression of many
germ cell markers (Carter et al., 2008). In
contrast, germ cell marker genes were
fully methylated in Oct4-GFP negative
as well as the positive EpiSCs, like in
MEFs, but not in ESCs or PGCs (Fig-ure 3F). Finally, parental nonsorted EpiSCs exhibited the same
methylation pattern as Oct4-GFP negative EpiSCs (data not
shown). These data further support the notion that Oct4-GFP
positive cells have an overall EpiSC identity that is neither ES-
like nor PGC-like.
In contrast, the methylation pattern of the Dppa5 promoter
was similar in Oct4-GFP positive EpiSCs and ESCs (Figure 3F).
This is consistent with the gene expression profiling data,
revealing increased Dppa5 expression in Oct4-GFP positive
EpiSCs compared with Oct4-GFP negative EpiSCs (Figure 3A).
These data suggest that Oct4-GFP positive cells differ from
Oct4-GFP negative cells in the expression of some prominent
ESCmarker genes, as reflected by differential epigenetic regula-
tion. These data further suggest that the dynamic interchange
between the Oct4-GFP positive and negative subpopulations
of EpiSCs appears to be regulated by a DNAmethylation-depen-
dent mechanism.
Oct4-GFP Positive and Negative EpiSCs Show Distinct
ESC Conversion Rates
Next, we asked whether these two EpiSC populations differ in
function. EpiSCs can be converted to an ES-like state by switch-
ing to stringent ESC culture conditions, the so-called 2i+LIF
medium (2i condition) (Greber et al., 2010; Guo et al., 2009;
Hanna et al., 2009). As Oct4-GFP positive cells exhibited upre-
gulation of some prominent ESC markers, we speculated that
Oct4-GFP positive EpiSCs can be converted more easily than
Oct4-GFP negative EpiSCs. Under the 2i condition, the conver-
sion efficiency of Oct4-GFP positive EpiSCs was much higher
compared with that of Oct4-GFP negative EpiSCs, as deter-
mined by the number of colonies staining positive for alkaline
phosphatase (Figures 4A and 4B). Remarkably, conversion ofovember 12, 2010 ª2010 Elsevier Inc. 621
Oct4-GFP positive EpiSCs was noted only in the presence of
2i+LIF, and not in EpiSC medium. Consistent with a previous
study (Bao et al., 2009), we also obtained converted ES-like cells
in typical ESC medium (LIF alone). However, we were unable to
maintain these converted cells with LIF alone (data not shown).
Thus, although Oct4-GFP positive cells do not represent ES-
like cells, they can be converted at substantially higher efficiency
than Oct4-GFP negative EpiSCs.
Finally, to definitively rule out the possibility that Oct4-GFP
positive EpiSCs are actually spontaneously converted ES-like
cells, we assessed the promoter methylation patterns of Stella,
Fragilis, Vasa, and Dppa5 in the ES-like cells that had been con-
verted from Oct4-GFP positive EpiSCs. The Stella promoter is
known to be differentially methylated in EpiSCs and ESCs (Bao
et al., 2009; Hayashi et al., 2008). As shown in Figure 4C, the con-
verted ES-like cells exhibited an imprinted DNA methylation
pattern of the Stella promoter, like ESCs, but a clearly different
pattern compared with Oct4-GFP positive EpiSCs, from which
they had been derived (Figure 3F). Similarly, the converted ES-
like cells exhibited hypomethylation of theRex1 promoter region,
but both Oct4-GFP positive and negative EpiSCs showed high
Rex1 promoter methylation (Figure S2). Moreover, the converted
ES-like cells also showed reduced DNA promoter methylation of
the germ cell markers Fragilis, Vasa, and Dppa5, like ESCs,
whereas Oct4-GFP positive EpiSCs exhibited hypermethylation
of these germ cell marker genes (Figure 4C and Figure 3F).
Therefore, the distinct DNA methylation pattern in Oct4-GFP
positive EpiSCs and converted ES-like cells allows us to defini-
tively rule out that the Oct4-GFP positive EpiSC subpopulation
represents EpiSCs that had spontaneously converted to an
ES-like state in EpiSC culture.
Oct4-GFP Positive and Negative EpiSCs
Represent Pregastrulation Epiblasts
of Different Developmental Stages
Oct4-GFP positive andOct4-GFP negative EpiSCs exhibit differ-
ential expression of some ESC marker genes (Figure 3A), distin-
guishable Dppa5 methylation pattern (Figure 3F), and distinct
ESC conversion efficiency (Figures 4A and 4B). Of interest,
Dppa5, which was less methylated in Oct4-GFP positive than
in Oct4-GFP negative EpiSCs (Figure 3F), is expressed in E5.5
epiblasts, but not in E6.5 epiblasts (Western et al., 2005). On
the other hand, the typical EpiSC marker T, which was highly
expressed inOct4-GFP negative comparedwithOct4-GFP posi-
tive EpiSCs, is more abundant in E6.5 epiblasts than in E5.5
epiblasts (Rivera-Pe´rez and Magnuson, 2005). These observa-
tions prompted us to investigate whether the cells with different
Oct4-GFP transgene expression actually correspond to in vivo
epiblasts of different developmental stages. For this purpose,
we compared the gene expression profiles of E5.5 and E6.5
in vivo epiblasts isolated from GOF18 mice. As epiblasts from
such an early stage contain a very limited number of cells, the
procedure of whole-genome profiling currently presents a
number of challenges. Also, as Oct4-GFP positive EpiSCs are
very similar to the parental EpiSCs based on microarray gene
analysis (Figure 3C), we sought to compare the specific genes
differentially expressed in Oct4-GFP positive and negative
EpiSCs. To this end, Oct4-GFP positive cells from both E5.5622 Cell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc.and E6.5 epiblasts were sorted and analyzed by real-time
PCR. Genes that were differentially expressed inOct4-GFP posi-
tive and negative EpiSCs (Figure 3A), such as Rex1 (Zfp42),
Esrrb, Fbxo15, Klf2, Klf4, Klf5, Stella, Dppa4, Dppa5, Dnmt3l,
Piwil2, Fragilis, and T, were selected for analysis. Consistent
with the microarray data, the majority of ESC markers were
highly expressed in both Oct4-GFP positive EpiSCs and E5.5
epiblasts compared with Oct4-GFP negative EpiSCs and E6.5
epiblasts, respectively (Figures 5A and 5B). On the other hand,
Fragilis and T were highly expressed in Oct4-GFP negative
EpiSCs and E6.5 epiblasts compared with Oct4-GFP positive
EpiSCs and E5.5 epiblasts, respectively (Figures 5A and 5B).
Thus, the expression patterns ofOct4-GFP positive and negative
EpiSCs correlate to those of E5.5 and E6.5 epiblasts, respec-
tively. Next, we used computational analysis to determine the
association between the EpiSC subpopulations and the in vivo
epiblasts of different stages. The heat map calculated with the
real-time RQ values again shows a very similar association (Fig-
ure 5C). Finally, the hierarchical clustering generated with the
real-time PCRdata clearly shows thatOct4-GFP positive EpiSCs
are similar to E5.5 epiblasts, whereas Oct4-GFP negative
EpiSCs rather represent E6.5 epiblasts (Figure S3).
Oct4 transcription is regulated through the DE in the ICM and
ESCs but through the PE in the epiblast and EpiSCs (Tesar
et al., 2007; Yeom et al., 1996). Using a luciferase assay, we
compared Oct4 enhancer utilization/activity in both Oct4-GFP
positive and negative EpiSCs. As a control, we used ES-like
cells that had been converted from Oct4-GFP positive EpiSCs.
Oct4-GFP negative EpiSCs specifically used the PE, and the
converted ES-like cells showed strong DE activity, as expected
(Figure 5D). Although converted ES-like cells are maintained in
the presence of 2i+LIF medium, spontaneous differentiation of
the converted cells into EpiSCs could explain the residual PE
activity observed. Accordingly, ESCs, which are derived directly
from the ICM, showed exactly the same enhancer utilization as
converted ES-like cells (data not shown). Of interest, Oct4-GFP
positive EpiSCs preferentially utilize the PE, but they also exhibit
some DE activity (Figure 5D). This unexpected DE activity in
Oct4-GFP positive EpiSCs, although lower than PE activity,
encouraged us to analyze the enhancer activity in early-stage
in vivo epiblasts. We isolated in vivo epiblasts (E5.5, E6.6, and
E7.5) from both GOF18 (containing DE and PE) and GOF18DPE
mice. As mentioned above, in vivo epiblasts and their in vitro
derivatives, EpiSCs, have been described to preferentially use
the PE for Oct4 transcription (Guo et al., 2009; Hanna et al.,
2009; Tesar et al., 2007; Yeom et al., 1996). The in vivo epiblasts
isolated from GOF18 mice on E5.5, E6.6, and E7.5 were GFP
positive, as expected (Figure 5E). However, the in vivo
GOF18DPE epiblasts (E5.5 and E6.5), which were supposed
to be GFP negative due to the absence of PE, were also GFP
positive, but GFP expression was clearly weaker than that in
GOF18 mice—i.e., the GFP signals were barely detectable
without overexposure, consistent with a previous report (Yoshi-
mizu et al., 1999). GFP intensity had gradually decreased in
E6.5, with GFP negative expression evident at E7.5, except
for PGCs (Figure 5E). This observation strongly suggests that
the early-stage epiblast still retains residual DE activity, together
with PE activity. Thus, the enhancer switch, an event widely
Figure 5. Oct4-GFP Positive and Negative EpiSCs Represent In Vivo Epiblasts of Different Developmental Stages
(A and B) Comparison of gene expression patterns in in vivo samples (E5.5 versus E6.5 epiblasts) (A) and in vitro samples (Oct4-GFP positive versus negative
EpiSCs) (B). Expression levels are normalized to those of E6.5 epiblast (A) and Oct4-GFP negative EpiSCs (B), respectively.
(C) Heat map of the RT-PCR values. RT-PCR RQ ratios were used to compare in vivo with in vitro samples. The in vivo ratios were calculated by dividing the
RT-PCRRQ value of the E6.5 epiblast by that of the E5.5 epiblast sample. The in vitro ratios were calculated by dividing the RT-PCRRQ value of the GFP negative
EpiSC sample by that of the GFP positive EpiSC sample. The color bar at top codifies the ratio values; red and blue colors indicate high and low ratios,
respectively.
(D) Evaluation of the Oct4 enhancer activity in Oct4-GFP positive and negative EpiSCs. Relative luciferase activity was normalized to the activity of the empty
vector. Data represent mean ± SEM of triplicates; n = 3.
(E) Dynamics of theOct4-GFP reporter expression in in vivo epiblasts. In vivo epiblasts were isolated from both GOF18 andGOF18DPEmice at E5.5, 6.5, and 7.5.
Oct4-GFP expression was measured under fluorescence microscope. To show specificOct4-GFP expression fromGOF18DPEmice, all images were taken with
the same overexposure, but the images from GOF18 mice were taken with normal exposure. The extra panel under the E7.5 GOF18DPE epiblast shows residual
Oct4-GFP expression in PGCs.
See also Figure S3.accepted to occur around the time of implantation (E4.5),
appears to occur later than expected. Therefore, the DE activity
observed in Oct4-GFP positive EpiSCs also correlates with
Oct4 enhancer utilization in early-stage epiblasts (Figures 5D
and 5E).
The enhancer utilization assay, combined with the real-time
PCR data, suggests that Oct4-GFP positive EpiSCs correspond
to an epiblast of an early developmental stage, whereas Oct4-
GFP negative EpiSCs are rather similar to an epiblast of a later
stage.
Oct4-GFP Positive EpiSCs Can Contribute to Chimeras
Gardner et al. reported that the PrE from E5 embryos is capable
of contributing to chimera formation by blastocyst injection,
unlike that from E6 and E7 embryos (Gardner et al., 1985). To
determine whether there is a functional difference between
Oct4-GFP positive and negative EpiSCs, just like between early-and late-stage in vivo epiblasts, we assessed whether these two
cell populations can contribute to chimeras. Consistent with
previous studies (Brons et al., 2007; Guo et al., 2009; Tesar
et al., 2007), upon injection of Oct4-GFP positive EpiSCs into
blastocysts, only 10% of the embryos showed ICM integration
(Figure 6A). Surprisingly, following transfer of these embryos,
germline contribution as well as coat-color chimerismwas noted
(Figures 6B and 6C and Table S1). However, we were unable to
observe any evidence of germline transmission with Oct4-GFP
positive EpiSCs (Table S1). To trace the fate of Oct4-GFP nega-
tive EpiSCs in reconstructed embryos, we first infected GOF18
EpiSCs with a Td-tomato lentivirus. We then established a new
Td-tomato GOF18 EpiSC line (Epi-Red) (Figure 6D). Tomato-
positive/Oct4-GFP negative cells were FACS sorted and injected
into blastocysts, but neither ICM integration (Figure 6E and Fig-
ure S4 available online) nor chimera contribution was observed
(Table S1). Thus, Oct4-GFP negative EpiSCs, which made upCell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc. 623
Figure 6. Oct4-GFP Positive EpiSCs Can Contribute to Chimera
Formation
(A) Integration of Oct4-GFP positive EpiSCs into the ICM following blastocyst
injection.
(B) Germline contribution of Oct4-GFP positive EpiSCs, as shown by the
expression ofOct4-GFP in the gonad of a 13.5 days postcoitum (dpc) embryo.
(C) Coat-color chimera from Oct4-GFP positive EpiSCs.
(D) Morphology of Epi-Red cells and expression of Td-tomato lentivirus.
(E) Epi-Red cells failed to integrate into the ICM following blastocyst injection.
See also Figure S4.99% of the EpiSCs in culture, had no developmental potential,
unlike Oct4-GFP positive EpiSCs.
Taken together, our data suggest that Oct4-GFP positive
EpiSCs represent cells of an early-stage epiblast (E5.5), whereas624 Cell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc.Oct4-GFP negative EpiSCs are rather similar to those of a late-
stage epiblast (E6.5 or E7.5).
Dppa5 Overexpression Increases the Early-Stage
Epiblast Fraction
We have demonstrated that EpiSCs are heterogeneous and
comprise two subpopulations—Oct4-GFP positive and negative
cells, representing early- and late-stage epiblasts, respectively.
Thus, we then tested whether overexpressing Dppa5, a gene
that is specifically expressed in early-stage epiblasts and
Oct4-GFP positive EpiSCs, but not in late-stage epiblasts and
Oct4-GFP negative EpiSCs, can increase theOct4-GFP positive
fraction. Dppa5-overexpressing EpiSCs showed an 6-fold
increase in Oct4-GFP positive cells compared with noninfected
EpiSCs (Figure 7A). We then FACS sorted the GFP positive cells
from Dppa5-overexpressing and control EpiSCs and cultured
them for another 10 passages (Figure 7B). Oct4-GFP positive
cells from both Dppa5-overexpressing and control EpiSCs
immediately started to lose Oct4-GFP expression. After two
passages, 10.5% of the Dppa5-overexpressing cells and 6.3%
of the control EpiSCs remained GFP positive. The number of
GFP positive cells from control EpiSCs continued to decrease
until levels reached those of the parental nonsorted EpiSCs—
1.3% at passage 4. However, GFP positive cells were stably
maintained in Dppa5-overexpressing EpiSCs at 4%–6%,
even after several passages. To exclude the possibility that
Dppa5 overexpression could revert EpiSCs to an ES-like state,Figure 7. Dppa5 Overexpression Increases
the Early-Stage Epiblast Fraction
(A) The Oct4-GFP positive fraction was increased
by overexpressing Dppa5. The numbers of Oct4-
GFP positive cells from both control and Dppa5-
overexpressing EpiSCs were compared by FACS.
(B) Dynamics of Oct4-GFP expression in FACS-
sorted GFP positive cells from both control and
Dppa5-overexpressing EpiSCs. FACS-sorted
Oct4-GFP positive cells were cultured for another
10 passages, and the number of Oct4-GFP posi-
tive cells was measured after every two passages.
(C) A dynamic interchange exists between ESCs
positive and negative for Stella (Dppa3), Nanog,
and Rex1 (Zfp42). When all three genes are ex-
pressed, ESCs represent the well-known ground
state of pluripotency. However, when the expres-
sion of one of these genes is reduced, the pluripo-
tent capability is also considerably reduced.
EpiSCs are also heterogeneous, with two different
populations distinguished byOct4-GFP transgene
expression. Oct4-GFP positive and negative
EpiSCs exist in a state of dynamic equilibrium
and correspond to in vivo epiblasts of early
and late stages of development, respectively.
The endogenous Oct4 locus is unmethylated and
expressed in both populations, whereas the
Oct4-GFP transgene is differentially methylated,
allowing to distinguish the early- and late-stage
epiblast subpopulations.
See also Figure S2.
Oct4-GFP cells were sorted from Dppa5-overexpressing
EpiSCs, and the methylation status of the Rex1 promoter was
assessed by bisulfite sequencing PCR. Rex1 promoter was
highly methylated, like in Oct4-GFP positive and negative
EpiSCs, indicating that the increasedOct4-GFP positive fraction
still maintains EpiSC identity rather than acquires an ES-like
state (Figure S2). Therefore, these data suggest that overexpres-
sion of Dppa5 increases the Oct4-GFP positive EpiSC fraction,
which represents early-stage epiblasts.
DISCUSSION
The pluripotency of a cell can be assessed by determining
the cell’s developmental potential both in vitro and in vivo. The
in vivo differentiation of cells to form both teratomas and
chimeras is a basic yet reliable tool for assessing a cell’s devel-
oping potency. Thus, cells that are pluripotent must meet these
two basic criteria. EpiSCs, however, exhibit limited developing
potency and thus have a unique pluripotential capacity
compared with other pluripotent stem cell lines from different
tissues of origin. The discrepancy in the potency of EpiSCs
observed with different developmental assays, together with
the heterogeneity of ESCs, prompted us to closely investigate
the pluripotential state of EpiSCs. To this end, we assessed
whether EpiSCs also exhibit heterogeneity, like ESCs. Our
results show that EpiSCs are not as homogeneous as previously
described (Hayashi et al., 2008; Toyooka et al., 2008). We have
taken advantage of the differential expression of an Oct4-GFP
transgene and have defined a novel type of EpiSCs. We found
a dynamic interchange of two distinct cell subpopulations of
EpiSCs that are in equilibrium in vitro: Oct4-GFP positive and
Oct4-GFP negative EpiSCs (Figure 7C). We speculate that the
distinct expression levels of the endogenous Oct4 and the
Oct4-GFP reporter result from an adaptation of the embryonal
epiblast to culture conditions during the establishment of the
EpiSCs, consistent with adaptive modifications described for
ESCs (Buehr and Smith, 2003; Rossant, 2001). Nevertheless,
using a luciferase assay, we showed that the two subpopulations
exhibit distinctOct4 enhancer utilization. Therefore, although we
discovered the existence of two types of EpiSCs—Oct4-GFP
positive and negative EpiSC subpopulations—based on distinct
transgene expression, this expression indeed represents distinct
enhancer activity of the endogenous Oct4 locus (Figures 5D
and 5E).
Bao et al. recently showed the spontaneous conversion of
EpiSCs to ES-like cells in ESC medium in the absence of exog-
enous transcription factors or small molecules (Bao et al., 2009).
To investigate whether Oct4-GFP positive EpiSCs represent
converted ES-like cells, we compared the distinctive features
of EpiSCs and ESCs. First, the global gene expression profile
of Oct4-GFP positive EpiSCs correlated with that of EpiSCs,
but not with ESCs (Figures 3C and 3D). Second, as the promoter
regions of Stella and Rex1 were shown to be hypomethylated in
ESCs but hypermethylated in EpiSCs (Bao et al., 2009; Hayashi
et al., 2008), we examined the methylation of these two genes as
a hallmark for discriminating EpiSCs from ESCs or converted
ES-like cells. Consistent with these previous studies, both the
Stella and Rex1 promoters, as well as other germ cell markergene promoters, were hypomethylated in ESCs but highly meth-
ylated in Oct4-GFP positive EpiSCs. In contrast, ES-like cells
that had been converted from Oct4-GFP positive EpiSCs
showed exactly the same DNA methylation pattern as ESCs.
Third, we investigated the signaling dependence of these cells
by comparing their Oct4 enhancer utilization. We found that
Oct4-GFP negative EpiSCs specifically use the PE, but con-
verted ES-like cells and ESCs preferentially use the DE rather
than the PE, as expected. Surprisingly, althoughOct4-GFP posi-
tive EpiSCs mainly use the PE, a lower DE activity could also be
detected, indicating that Oct4-GFP positive EpiSCs have a
completely different pattern of Oct4 enhancer utilization than
ESCs. Taken together, these results show that Oct4-GFP posi-
tive EpiSCs are not converted ES-like cells.
We have also demonstrated that Oct4-GFP positive and
negative EpiSCs correspond to developing epiblasts of two
different stages. In terms of gene expression profile, Oct4-GFP
positive EpiSCs correlate with E5.5 epiblasts and Oct4-GFP
negative EpiSCs with E6.5 epiblasts. Moreover, Oct4 enhancer
utilization of Oct4-GFP positive EpiSCs resembles that of early
epiblasts (E5.5). Therefore, Oct4-GFP positive EpiSCs repre-
sent early-stage in vivo epiblast cells, whereas Oct4-GFP nega-
tive EpiSCs, the majority of EpiSCs, represent late-stage in vivo
epiblast cells.
Finally, we compared the developmental potential of Oct4-
GFP positive and negative EpiSCs. Although germline transmis-
sion could not be observed, Oct4-GFP positive EpiSCs could
incorporate into the ICM and even contribute to the germline,
unlike Oct4-GFP negative EpiSCs. PrE cells from E5 embryos
retain the ability to give rise to adult chimeras, whereas PrE cells
from E6 and E7 embryos have lost this ability (Gardner et al.,
1985). Therefore, in terms of gene expression profile, epigenetic
status, specific Oct4 enhancer utilization, and even functional
developmental capacity, Oct4-GFP positive and negative
EpiSCs represent in vivo epiblasts of early and late develop-
mental stages, respectively. EpiSCs rarely exhibit chimeric
contribution, with the chimera rate (0.5%) correlating with the
percentage of Oct4-GFP positive cells in GOF18 EpiSCs (Brons
et al., 2007). Thus, it is likely that the cells that contribute to
chimera formation are the EpiSCs of an early in vivo epiblast—
i.e., Oct4-GFP positive EpiSCs.
Taken together, our findings demonstrate that EpiSC cultures
are heterogeneous and comprise Oct4-GFP positive and nega-
tive EpiSC cell subpopulations that are in a state of dynamic
equilibrium and that correspond to in vivo epiblasts of early
and late developmental stages, respectively (Figure 7C). More-
over, our data also suggest that the introduction of an early-
stage-specific transcription factor, such as Dppa5, could
increase the EpiSC subpopulation that represents early-stage
epiblasts (Figures 7A and 7B). Therefore, investigations with
EpiSCs derived from GOF18 mice offer opportunities to
better understand early embryonic development, differentiation
processes, and germ cell development, as well as the devel-
oping potency of in vivo epiblasts of different developmental
stages. As EpiSCs havemany properties in common with human
ESCs, it would be interesting to assess whether human ESCs
also exhibit heterogeneity, similar to EpiSCs, which may affect
the therapeutic potential of these cells.Cell 143, 617–627, November 12, 2010 ª2010 Elsevier Inc. 625
EXPERIMENTAL PROCEDURES
Cell Culture
The derivation and characterization of GOF18 EpiSCs is described elsewhere
(Greber et al., 2010). In brief, E5.5 embryos (129/Sv female 3 C56/Bl6 and
DBA/2 background GOF18+/+ male) were collected and transferred into
HBSS medium. For dissection, deciduas were removed with forceps, and
the extraembryonic ectoderm was separated from the epiblast by using
hand-pulled glass pipettes. After washing with PBS, the epiblast was cultured
on MEFs in EpiSC medium: DMEM/F12 (GIBCO BRL) containing 20%
knockout serum replacement (GIBCO BRL), 2 mM glutamine, 13 nonessential
amino acids, and 5 ng/ml bFGF. After initial culture on MEFs for three to five
passages, EpiSC colonies were picked and transferred onto dishes that had
been precoated with FCS for 30 min. Feeder-free EpiSCs were cultured in
MEF (CF1 mice) conditioned medium. For conditioning, irradiated MEFs
were seeded at a density of 53 104 cells/cm2 and incubated in EpiSCmedium
for 24 hr. The conditioned medium was filtered, and bFGF (5 ng/ml) was
added. For passaging feeder-free EpiSCs, colonies were incubated with colla-
genase IV (Invitrogen) for 5 min at 37C and triturated by using a cell scraper.
Cell clumps were replated on FCS-coated dishes, and the medium was
changed every 24 hr.
DNA Methylation Analysis
DNAmethylation status of EpiSCs was determined by the bisulfite sequencing
method from our published protocol (Han et al., 2009). Detailed protocols,
including PCR conditions and primer sequences, are described in our previous
study (Han et al., 2008) and in the Extended Experimental Procedures.
Whole-Genome Expression Analysis
Global gene expression profiling was performed with the Illumina microarray.
Detailed protocols are described in the Extended Experimental Procedures.
Blastocyst Injection
Blastocysts were collected from B6C3F1 mice. EpiSCs were recovered by
treatment with collagenase IV or 0.25% trypsin EDTA, and 10–15 cells were
loaded into an injection pipette and injected into B6C3F1 blastocysts by Piezo
(Prime-tech). Each of the 15 injected blastocysts was transferred into the
uterus of a pseudopregnant ICR mouse.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and one table and can be found with this article online at doi:
10.1016/j.cell.2010.10.015.
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